Clare Ozawa of South San Francisco, CA appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. Clare Ozawa appears on 18 filing roles across Form D (17), Form ADV (1).
| Filed | Source | Entity | Role | Location |
|---|---|---|---|---|
| 2025-03-27 | Form ADV | VERSANT VENTURE MANAGEMENT, LLC | MANAGING MEMBER, VERSANT VENTURES VII GP-GP, LLC | SAN FRANCISCO, CA |
| 2018-06-26 | Form D | Mistral Therapeutics, Inc. | Director | SAN DIEGO, CA |
| 2015-12-28 | Form D | Inception IBD, Inc. | Executive Officer | SAN DIEGO, CA |
| 2023-03-10 | Form D | Lenz Therapeutics, Inc. | Director | DEL MAR, CA |
| 2018-12-17 | Form D | Versant Venture Capital VII, L.P. | Director | SAN FRANCISCO, CA |
| 2019-03-08 | Form D | Versant Vantage I, L.P. | Director | SAN FRANCISCO, CA |
| 2026-06-25 | Form D | Lycia Therapeutics, Inc. | Related Person | SOUTH SAN FRANCISCO, CA |
| 2024-07-11 | Form D | 858 Therapeutics, Inc. | Director | SAN DIEGO, CA |
| 2022-09-23 | Form D | March Therapeutics, Inc. | Director | CAMBRIDGE, MA |
| 2020-09-24 | Form D | Jengu Therapeutics, Inc. | Director | SAN DIEGO, CA |
| 2021-04-15 | Form D | Versant Vantage II, L.P. | Executive Officer | SAN FRANCISCO, CA |
| 2021-04-15 | Form D | Versant Voyageurs II (Canada), L.P. | Executive Officer | SAN FRANCISCO, CA |
| 2021-04-15 | Form D | Versant Venture Capital VIII (Canada), L.P. | Executive Officer | SAN FRANCISCO, CA |
| 2023-04-07 | Form D | Versant Venture Capital IX (Canada), L.P. | Executive Officer | SAN FRANCISCO, CA |
| 2023-04-07 | Form D | Versant Voyageurs III, L.P. | Executive Officer | SAN FRANCISCO, CA |
| 2022-10-11 | Form D | Versant Vantage III (Canada), L.P. | Executive Officer | SAN FRANCISCO, CA |
| 2023-04-07 | Form D | Versant Vantage III, L.P. | Executive Officer | SAN FRANCISCO, CA |
| 2024-05-09 | Form D | Versant Venture Capital SPV I (SAB), L.P. | Executive Officer | SAN FRANCISCO, CA |